| Literature DB >> 34688141 |
Jinyue Sun1, Debao Wang1, Zhilan Sun1, Fang Liu2, Lihui Du3, Daoying Wang1.
Abstract
This study aimed to investigate the mechanism of different treatments, namely, ultrasound (US), chlorogenic acid (CA), and ultrasound combined with chlorogenic acid (US plus CA) on the inactivation of Staphylococcus aureus planktonic and biofilm cells. Results showed that the combined treatment of US and CA exhibited remarkable synergistic antibacterial and antibiofilm effects. Scanning electron microscopy images indicated that the combined treatment of US and CA caused the most serious damage to the cell morphology. Confocal laser scanning microscopy images revealed that the combined treatment led to sharp increase and severe damage to the permeability of the cell membrane, causing the release of ATP and nucleic acids and decreasing the exopolysaccharide contents in S. aureus biofilm. Finally, the combined treatment of US plus 1% CA for 60 min inactivated S. aureus cells by 1.13 lg CFU/g on mutton. Thus, the combined treatment of US and CA had synergistic effect against S. aureus under planktonic, biofilm, and food systems.Entities:
Keywords: Biofilm; Chlorogenic acid; Planktonic cells; S. aureus; Ultrasound
Mesh:
Substances:
Year: 2021 PMID: 34688141 PMCID: PMC8551818 DOI: 10.1016/j.ultsonch.2021.105801
Source DB: PubMed Journal: Ultrason Sonochem ISSN: 1350-4177 Impact factor: 7.491
Inactivation of S. aureus planktonic cells by different treatment.
| Treatments | |||||
|---|---|---|---|---|---|
| 5 | 10 | 20 | 30 | 60 | |
| Control | 9.40 ± 0.08A | 9.36 ± 0.12A | 9.34 ± 0.09A | 9.42 ± 0.02A | 9.38 ± 0.12A |
| US | 9.27 ± 0.09A | 9.26 ± 0.09A | 9.13 ± 0.04B | 9.11 ± 0.04B | 9.03 ± 0.02B |
| 0.5% CA | 9.07 ± 0.07B | 8.99 ± 0.06B | 8.77 ± 0.09C | 8.52 ± 0.12C | 6.47 ± 0.03C |
| 1% CA | 8.97 ± 0.04BC | 8.75 ± 0.06CD | 8.46 ± 0.10D | 7.64 ± 0.13D | 4.94 ± 0.06E |
| 2% CA | 8.86 ± 0.04CD | 8.67 ± 0.05DE | 7.05 ± 0.13E | 6.02 ± 0.08F | 3.35 ± 0.20D |
| US plus 0.5% CACA | 9.00 ± 0.05BC | 8.87 ± 0.04BC | 8.64 ± 0.02C | 7.24 ± 0.13E | 3.71 ± 0.10F |
| US plus 1% CA | 8.90 ± 0.03CD | 8.75 ± 0.02CD | 7.01 ± 0.09F | 4.90 ± 0.06G | 3.00 ± 0.20G |
| US plus 2% CA | 8.80 ± 0.13D | 8.62 ± 0.07E | 5.84 ± 0.07G | 2.52 ± 0.09H | ≤1.4 |
Different lower cases indicate significant differences among treatments (p < 0.05).
Inactivation of S. aureus biofilm cells by different treatments.
| Treatments | |||||
|---|---|---|---|---|---|
| 5 | 10 | 20 | 30 | 60 | |
| Control | 9.43 ± 0.02A | 9.42 ± 0.04A | 9.42 ± 0.08A | 9.43 ± 0.05A | 9.42 ± 0.10A |
| US | 9.35 ± 0.04B | 9.31 ± 0.02B | 9.28 ± 0.01B | 9.21 ± 0.04B | 9.00 ± 0.05B |
| 0.5% CA | 9.30 ± 0.04B | 9.21 ± 0.11C | 9.08 ± 0.06C | 8.35 ± 0.04C | 6.75 ± 0.10C |
| 1% CA | 9.25 ± 0.06C | 9.12 ± 0.02C | 8.34 ± 0.10D | 7.63 ± 0.16E | 4.60 ± 0.12D |
| 2% CA | 9.09 ± 0.03D | 8.95 ± 0.02D | 6.99 ± 0.09F | 6.68 ± 0.05F | 4.21 ± 0.06E |
| US plus 0.5% CACA | 9.03 ± 0.03D | 8.85 ± 0.04E | 8.20 ± 0.02E | 8.03 ± 0.20D | 3.83 ± 0.15F |
| US plus 1% CA | 8.98 ± 0.05E | 8.69 ± 0.05F | 6.90 ± 0.13F | 5.02 ± 0.07G | 3.57 ± 0.08G |
| US plus 2% CA | 8.86 ± 0.08F | 8.55 ± 0.06G | 6.06 ± 0.06G | 3.90 ± 0.23H | 3.10 ± 0.11H |
Different lower cases indicate significant differences among treatments (p < 0.05).
Fig. 1SEM images of S. aureus planktonic and biofilm cells treated with control, US, 2% CA, and US plus 2% CA.
Fig. 2CLSM images of S. aureus planktonic and biofilm cells treated with control, US, 2% CA, and US plus 2%CA.
Fig. 3Soluble and insoluble polysaccharide contents in S. aureus biofilms after different treatments. Different lower case letters indicate significant differences among treatments (p < 0.05).
Measurements of ATP released from S. aureus planktonic and biofilm cells after treatment with US, CA, and US plus CA.
| Treatments | ATP concentration (nmol/ OD) | |
|---|---|---|
| Control | 16.71 ± 2.75A | 8.96 ± 0.85A |
| US | 27.91 ± 2.60B | 20.61 ± 2.30B |
| 0.5% CA | 40.97 ± 3.60C | 38.65 ± 4.90C |
| 1% CA | 50.87 ± 3.13D | 58.96 ± 9.43D |
| 2% CA | 102.97 ± 3.16F | 145.74 ± 3.29F |
| US plus 0.5% CA | 81.31 ± 9.15E | 55.85 ± 5.52D |
| US plus 1% CA | 142.40 ± 9.07G | 116.21 ± 6.19E |
| US plus 2% CA | 205.5 ± 5.53H | 189.46 ± 6.62G |
Different lower-case letters indicate significant differences among treatments (p < 0.05).
Measurements of nucleic acids released from S. aureus planktonic and biofilm cells after treatment with US, CA, and US plus CA.
| Treatments | OD260 | |
|---|---|---|
| Control | 0.31 ± 0.022A | 0.12 ± 0.022A |
| US | 0.40 ± 0.005B | 0.17 ± 0.012B |
| 0.5% CA | 0.57 ± 0.010C | 0.23 ± 0.010C |
| 1% CA | 0.69 ± 0.005D | 0.57 ± 0.001E |
| 2% CA | 1.42 ± 0.009F | 0.68 ± 0.003F |
| US plus 0.5% CA | 0.87 ± 0.005E | 0.55 ± 0.002D |
| US plus 1% CA | 1.56 ± 0.009G | 0.88 ± 0.003G |
| US plus 2% CA | 2.24 ± 0.043H | 1.10 ± 0.030H |
Different lower-case letters indicate significant differences among treatments (p < 0.05).
Fig. 4Survival of S. aureus in mutton after treatment with US plus 1% CA. Different lower case letters indicate significant differences among treatments (p < 0.05).